1. Home
  2. HCAI vs EVGN Comparison

HCAI vs EVGN Comparison

Compare HCAI & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

N/A

Current Price

$0.35

Market Cap

11.7M

ML Signal

N/A

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$1.06

Market Cap

9.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAI
EVGN
Founded
2004
1999
Country
China
Israel
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
9.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
HCAI
EVGN
Price
$0.35
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
102.4K
47.4K
Earning Date
05-15-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$19,176,987.00
$8,016,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$97.31
N/A
Revenue Growth
N/A
7.19
52 Week Low
$0.28
$0.93
52 Week High
$10.97
$2.42

Technical Indicators

Market Signals
Indicator
HCAI
EVGN
Relative Strength Index (RSI) 54.71 49.14
Support Level $0.32 $1.00
Resistance Level $0.36 $1.08
Average True Range (ATR) 0.02 0.05
MACD 0.01 0.00
Stochastic Oscillator 98.18 40.00

Price Performance

Historical Comparison
HCAI
EVGN

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: